Four Weeks Administration Schedule of Ropeginterferon Alfa-2b (AOP2014/P1101) in Polycythemia Very Patients Allows Maintaining of Efficacy with Favorable Toxicity Profile in the Phase I/II Peginvera Stud
Autor: | Buxhofer-Ausch, Veronika *, Gisslinger, Heinz, Thaler, Josef *, Schlögl, Ernst *, Gastl, Gunther, Wolf, Dominik *, Kralovics, Robert, Gisslinger, Bettina *, Ban, Sarita *, Egle, Alexander, Melchardt, Thomas *, Burgstaller, Sonja *, Willenbacher, Ella *, Schalling, Martin *, Krauth, Maria Theresa *, Them, Nicole C.C. *, Zörer, Michael *, Ammann-Mwathi, Oliver *, Kadlecova, Pavla *, Zagrijtschuk, Oleh *, Klade, Christoph *, Greil, Richard |
---|---|
Zdroj: | In Blood 3 December 2015 126(23):1603-1603 |
Databáze: | ScienceDirect |
Externí odkaz: |